Open an account

CannaPharmaRx

CPMD · OTC

$0.002+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About CPMD

CannaPharmaRx, Inc. engages in the evaluation, negotiation, acquisition, and development of cannabis cultivation projects in Canada. The company is headquartered in Calgary, Alberta and currently employs 26 full-time employees. The firm operates from its facility in Cremona, Alberta, Canada and is able to produce over 6,000 kilograms per year. The firm is focused on the acquisition, development, and operation of cannabis cultivation facilities in Canada. The firm produces and sells dried cannabis flower, which is packaged for sale as dried flower and trim shake. The company sells dried flowers for medicinal purposes. The firm's products include unique genetics, craft products, medical cannabis, its brands and licenses. Craft cannabis, also known as craft marijuana, is cannabis that is produced on a small scale by artisanal or independent producers.

Employees
26
Headquarters
Calgary, Alberta
Listed
Oct 29, 1999
Sector
Health Care
Industry
Pharmaceuticals
Website
cannapharmarx.com

CPMD key statistics

Market cap
1.42M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
50.74K
Volume
500.00K
Open price
$0.002
High today
$0.002
Low today
$0.002
52 Week high
$0.01
52 Week low
$0.0003

CannaPharmaRx (CPMD) at a glance

As of Oct 23, 2026, CannaPharmaRx (CPMD) shares are priced at $0.002, giving the company a market cap of 1.42M and a price-to-earnings ratio of 0.00.

Volume so far is 500.00K shares, above the average of 50.74K shares a day.

Over the past year CannaPharmaRx has ranged from $0.0003 to $0.01, and now sits 18% of the way up that range.

CannaPharmaRx met or beat analyst EPS estimates in 1 of the last 5 quarters. In Q3 FY00 it reported -$6.30 per share against an estimate of -$5.61.

CPMD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 5 quarters, by 31.5% on average.

  1. Q3 FY99: reported -$5.00 per share against an estimate of -$4.28
  2. Q4 FY99: reported -$4.20 per share against an estimate of -$2.86
  3. Q1 FY00: reported -$5.00 per share against an estimate of -$2.65
  4. Q2 FY00: reported -$5.80 per share against an estimate of -$8.47
  5. Q3 FY00: reported -$6.30 per share against an estimate of -$5.61

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.